Negara: Armenia
Bahasa: Inggris
Sumber: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
extract of apple tree mistletoe
Helixor Heilmittel GmbH Fischermuehle 2
առկա չէ
extract of apple tree mistletoe
100mg/2ml
solution for injection
(6) ampoules 2ml
Prescription
Registered
2022-09-08
PIL_Armenien_HxAM_V2_xx-20220618_2020310 2022-06-24 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT NAME OF THE MEDICINAL PRODUCT Helixor ® A 1 mg Helixor ® M 1 mg Helixor ® A 5 mg Helixor ® M 5 mg Helixor ® A 20 mg Helixor ® M 20 mg Helixor ® A 50 mg Helixor ® M 50 mg Helixor ® A 100 mg Helixor ® M 100 mg Active substance: Extract of fir mistletoe Active substance: Extract of apple tree mistletoe Solution for injection Dear Patient, PLEASE READ THE ENTIRE INFORMATION LEAFLET CAREFULLY. IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. THIS PATIENT INFORMATION LEAFLET COVERS THE FOLLOWING TOPICS: 1. What is Helixor ® and what is it used for? 2. Before you use Helixor ® 3. How to use Helixor ® 4. Possible side effects 5. How to store Helixor ® 6. Contents of the package and other information 1. WHAT IS HELIXOR ® AND WHAT IS IT USED FOR? 1.1 Helixor ® is herbal medicine used in the complementary treatment of cancer. 1.2 The therapeutic indications include the following. In adults: stimulating the formative and integrative forces that dissolve and reintegrate autonomous growth processes. This includes conditions such as malignant tumors (as well as concomitant disorders of the hematopoietic system), benign tumors, defined precancerous conditions and for prophylaxis of recurrence after tumor surgery. 2. BEFORE YOU USE HELIXOR ® 2.1 HELIXOR ® MAY NOT BE USED if you are under the age of 18 years during pregnancy or lactation if you are allergic to mistletoe drugs if you currently have an acute infectious or febrile disease if you have an autoimmune disease which is in an Baca dokumen lengkapnya
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Helixor A 1 mg Helixor M 1 mg Helixor A 5 mg Helixor M 5 mg Helixor A 20 mg Helixor M 20 mg Helixor A 50 mg Helixor M 50 mg Helixor A 100 mg Helixor M 100 mg Active substance: Active substance: Extract of fir mistletoe Extract of apple tree mistletoe _(Viscum album ssp. abietis) _ _(Viscum album ssp. album) _ Solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION BY ACTIVE SUBSTANCES 1 ampoule of 1 ml contains: Active substance: Extract of fresh fir mistletoe / apple tree mistletoe (DER = 1 :20) x mg* Extraction agent: water for injection, sodium chloride (99.91 : 0.09) NAME OF THE PRODUCT AND STRENGTH *X MG QUANTITY OF EXTRACT Helixor A/M 1 mg 20 mg Helixor A/M 5 mg 101 mg Helixor A/M 20 mg 402 mg Helixor A/M 50 mg 1006 mg 1 ampoule Helixor A/M 100 mg of 2 ml contains: Active substance: Extract of fresh fir mistletoe / apple tree mistletoe (ratio of plant to extract = 1 :20) 2,012 mg Extraction agent: water for injection, sodium chloride (99.91 : 0.09) The dosage strength stated in mg indicates the amount of fresh plant material, which was used to manufacture 1 ampoule of Helixor. For example: One ampoule “Helixor A/M 1 mg” contains the extract of one mg of fresh mistletoe. The complete list of excipients is listed under Section 6.1. 3. PHARMACEUTICAL FORM Solution for injection 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In adults: stimulating the formative and integrative forces that dissolve and reintegrate autonomous growth processes, _e.g._ - malignant tumors (as well as concomitant disorders of the hematopoietic system) - benign tumors - defined precancerous conditions - for prophylaxis of recurrence after tumor surgery SUMMARY OF PRODUCT CHARACTERISTICS 2 4.2 POSOLOGY AND METHOD OF ADMINISTRATION INDUCTION THERAPY Unless otherwise directed, treatment begins with one ampoule of 1 mg Helixor A, M or P. _If _ _tolerability is good, the dosage is gradually increased by means of the different strengths: 1, 5, 20, 50 _ Baca dokumen lengkapnya